1. Home
  2. RYN vs BLCO Comparison

RYN vs BLCO Comparison

Compare RYN & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Rayonier Inc. REIT

RYN

Rayonier Inc. REIT

HOLD

Current Price

$21.57

Market Cap

6.4B

Sector

Real Estate

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$16.71

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
RYN
BLCO
Founded
1926
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Ophthalmic Goods
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.4B
5.4B
IPO Year
1994
2022

Fundamental Metrics

Financial Performance
Metric
RYN
BLCO
Price
$21.57
$16.71
Analyst Decision
Buy
Buy
Analyst Count
4
11
Target Price
$26.00
$18.45
AVG Volume (30 Days)
2.1M
417.0K
Earning Date
05-06-2026
04-29-2026
Dividend Yield
11.73%
N/A
EPS Growth
26.78
N/A
EPS
N/A
N/A
Revenue
$484,485,000.00
$5,101,000,000.00
Revenue This Year
$214.97
$8.65
Revenue Next Year
$10.35
$5.59
P/E Ratio
N/A
N/A
Revenue Growth
N/A
6.47
52 Week Low
$19.49
$13.53
52 Week High
$27.34
$18.92

Technical Indicators

Market Signals
Indicator
RYN
BLCO
Relative Strength Index (RSI) 50.52 56.83
Support Level $20.98 $16.74
Resistance Level $21.85 $17.61
Average True Range (ATR) 0.56 0.54
MACD -0.01 0.05
Stochastic Oscillator 38.93 76.45

Price Performance

Historical Comparison
RYN
BLCO

About RYN Rayonier Inc. REIT

Rayonier Inc is a timberland real estate investment trust engaged in the ownership, management, and investment of timberlands. The company operates through Southern Timber, Pacific Northwest Timber, and Real Estate segments. The Southern Timber and Pacific Northwest Timber segments are involved in harvesting timber and related activities, as well as value-added services such as licensing properties for hunting, leasing land for mineral extraction and communication infrastructure, land-based solutions including carbon capture and solar energy, and log trading. The Real Estate segment is engaged in land sales across various categories, as well as residential and commercial leasing activities. It generates the majority of its revenue from the Southern Timber segment.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: